Stereoelectroencephalography in pre-surgical evaluation of patients with drug-resistant focal epilepsy

Background. Surgical treatment has shown its effectiveness for patients with drug-resistant focal epilepsy: resection or disconnection of the epileptogenic zone leads to relief from epileptic seizures. However, in some cases non-invasive examination may not be sufficient for localization of epileptogenic zone boundaries. Hence, such patients undergo invasive encephalography (EEG) to clarify zone location accounting for seizure development.

Objective: to evaluate effectiveness of invasive stereo-EEG in the diagnostics of drug-resistant focal epilepsy.

Material and methods. The data collected from 65 patients who underwent stereo-EEG during pre-surgical examination for pharmacoresistant focal epilepsy were retrospectively analyzed within the period of 2016–2019. According to the results of magnetic resonance imaging (MRI), 34 patients had MRI-negative forms of epilepsy, and 31 patients had MRI-positive forms with multiple structural changes in the brain or discrepancies between electro-clinical data and MRI findings.

Results. Based on the information obtained by stereo-EEG, 49 patients (75.4%) underwent resection operations. In 16 (24.6%) cases surgical treatment was not carried out due to detected bilateral epileptogenic zone, the lack of convincing data on its location or detecting an epileptogenic zone in a functionally significant region. In 44 operated patients, the follow-up comprised more than 12 months; it was not possible to contact 5 patients. Engel outcomes: I class – 27 (61.3%) patients, II class – 7 (15.9%), III class – 4 (9.1%), IV class – 6 (13.6%). As a result of stereo-EEG, hemorrhagic complications developed in 2 (3.1%) patients: epidural hematoma in 1 case (1.5%), and intracerebral hematoma in 1 case (1.5%). No persistent neurological deficit was noted during continued monitoring.

Conclusion. The method of stereo-EEG is effective for determining the epileptogenic zone boundaries in patients with drug- resistant focal epilepsy.

1. Remy S., Beck H. Molecular and cellular mechanisms of pharmacoresistance in epilepsy. Brain. 2006; 129 (Pt. 1): 18–35. https://doi.org/10.1093/brain/awh682.

2. Mula M., Cock H.R. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol. 2015; 22 (1): 24–30. https://doi.org/10.1111/ene.12603.

3. Wiebe S., Blume W.T., Girvin J.P., Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001; 345 (5): 311–8. https://doi.org/10.1056/NEJM200108023450501.

4. Krylov V.V., Guekht A.B., Trifonov I.S., et al. Outcomes of surgical treatment of patients with pharmacoresistant epilepsy. S.S. Korsakov Journal of Neurology and Psychiatry. 2016; 116 (9-2): 13–8 (in Russ.). https://doi.org/10.17116/jnevro20161169213-18.

5. Dwivedi R., Ramanujam B., Chandra P.S., et al. Surgery for drug- resistant epilepsy in children. N Engl J Med. 2017; 377 (17): 1639–47. https://doi.org/10.1056/NEJMoa1615335.

6. Bancaud J., Talairach J. Epilepsy of the supplementary motor area: a particularly difficult diagnosis in children. Rev Neuropsychiatr Infant. 1965; 13 (6): 483–99 (in French).

7. Lüders H.O., Engel J. Jr., Munari C. General principles. In: Engel J. Jr. (Ed.) Surgical treatment of the epilepsies. 2nd ed. New York, NY: Raven Press, Ltd; 1993: 137–53.

8. Duncan J.S. Selecting patients for epilepsy surgery: synthesis of data. Epilepsy Behav. 2011; 20 (2): 230–2. https://doi.org/10.1016/j.yebeh.2010.06.040.

9. Ryvlin P., Cross J.H., Rheims S. Epilepsy surgery in children and adults. Lancet Neurol. 2014; 13 (11): 1114–26. https://doi.org/10.1016/S1474-4422(14)70156-5.

10. Thadani V.M., Williamson P.D., Berger R., et al. Successful epilepsy surgery without intracranial EEG recording: criteria for patient selection. Epilepsia. 1995; 36 (1): 7–15. https://doi.org/10.1111/j.1528-1157.1995.tb01658.x.

11. Kilpatrick C., Cook M., Kaye A., et al. Non-invasive investigations successfully select patients for temporal lobe surgery. J Neurol Neurosurg Psychiatry. 1997; 63 (3): 327–33. https://doi.org/10.1136/jnnp.63.3.327.

12. Diehl B., Lüders H.O. Temporal lobe epilepsy: when are invasive recordings needed? Epilepsia. 2000; 41 (Suppl. 3): S61–74. https://doi.org/10.1111/j.1528-1157.2000.tb01536.x.

13. Chapman K., Wyllie E., Najm I., et al. Seizure outcome after epilepsy surgery in patients with normal preoperative MRI. J Neurol Neurosurg Psychiatry. 2005; 76 (5): 710–3. https://doi.org/10.1136/jnnp.2003.026757.

14. McGonigal A., Bartolomei F., Régis J., et al. Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy. Brain. 2007; 130 (Pt. 12): 3169–83. https://doi.org/10.1093/brain/awm218.

15. Jayakar P., Gotman J., Harvey A.S., et al. Diagnostic utility of invasive EEG for epilepsy surgery: indications, modalities, and techniques. Epilepsia. 2016; 57 (11): 1735–47. https://doi.org/10.1111/epi.13515.

16. Fountas K.N. Implanted subdural electrodes: safety issues and complication avoidance. Neurosurg Clin N Am. 2011; 22 (4): 519–31, vii. https://doi.org/10.1016/j.nec.2011.07.009.

17. Cardinale F., Cossu M., Castana L., et al. Stereoelectroencephalography: surgical methodology, safety, and stereotactic application accuracy in 500 procedures. Neurosurgery. 2013; 72 (3): 353–66. https://doi.org/10.1227/NEU.0b013e31827d1161.

18. González-Martínez J., Bulacio J., Thompson S., et al. Technique, results, and complications related to robot-assisted stereoelectroencephalography. Neurosurgery. 2016; 78 (2): 169–80. https://doi.org/10.1227/NEU.0000000000001034.

19. Bourdillon P., Ryvlin P., Isnard J., et al. Stereotactic electroencephalography is a safe procedure, including for insular implantations. World Neurosurg. 2017; 99: 353–61. https://doi.org/10.1016/j.wneu.2016.12.025.

20. von Oertzen T.J., Mormann F., Urbach H., et al. Prospective use of subtraction ictal SPECT coregistered to MRI (SISCOM) in presurgical evaluation of epilepsy. Epilepsia. 2011; 52 (12): 2239–48. https://doi.org/10.1111/j.1528-1167.2011.03219.x.

21. Chen T., Guo L. The role of SISCOM in preoperative evaluation for patients with epilepsy surgery: a meta-analysis. Seizure. 2016; 41: 43–50. https://doi.org/10.1016/j.seizure.2016.06.024.

22. Karpov O.E., Bronov O.Yu., Vahromeeva M.N., et al. SISCOM protocol in diagnostics of epilepsia. Bulletin of Pirogov National Medical & Surgical Center. 2018; 13 (3): 75–8 (in Russ.). https://doi.org/10.25881/BPNMSC.2018.33.29.016.

23. Chassoux F., Navarro V., Catenoix H., et al. Planning and management of SEEG. Neurophysiol Clin. 2018; 48 (1): 25–37. https://doi.org/10.1016/j.neucli.2017.11.007.

24. Zuev A.A., Golovteev A.L., Pedyash N.V., et al. Possibilities for surgical treatment of the pharmacoresistant form of epilepsy using robot- assisted implantation of deep electrodes for invasive stereoelectroencephalography. Russian Journal of Neurosurgery. 2020; 22 (1): 12–20 (in Russ.). https://doi.org/10.17650/1683-3295-2020-22-1-12-20.

25. Engel J. Jr., Van Ness P.C., Rasmussen T.B., Ojemann L.M. Outcome with respect to epileptic seizures. In: Engel J. Jr. (Ed.) Surgical treatment of the epilepsies. 2nd ed. New York, NY: Raven Press; 1993: 609–21.

26. Blümcke I., Thom M., Aronica E., et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011; 52 (1): 158–74. https://doi.org/10.1111/j.1528-1167.2010.02777.x.

27. Téllez-Zenteno J.F., Hernández Ronquillo L., Moien-Afshari F., Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010; 89 (2-3): 310–8. https://doi.org/10.1016/j.eplepsyres.2010.02.007.

28. Engel J. Jr., McDermott M.P., Wiebe S., et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012; 307 (9): 922–30. https://doi.org/10.1001/jama.2012.220.

29. Jobst B.C., Cascino G.D. Resective epilepsy surgery for drug-resistant focal epilepsy: a review. JAMA. 2015; 313 (3): 285–93. https://doi.org/10.1001/jama.2014.17426.

30. Vadera S., Mullin J., Bulacio J., et al. Stereoelectroencephalography following subdural grid placement for difficult to localize epilepsy. Neurosurgery. 2013; 72 (5): 723–9. https://doi.org/10.1227/NEU.0b013e318285b4ae.

31. Serletis D., Bulacio J., Bingaman W., et al. The stereotactic approach for mapping epileptic networks: a prospective study of 200 patients. J Neurosurg. 2014; 121 (5): 1239–46. https://doi.org/10.3171/2014.7.JNS132306.

32. Jehi L.E., Silveira D.C., Bingaman W., Najm I. Temporal lobe epilepsy surgery failures: predictors of seizure recurrence, yield of reevaluation, and outcome following reoperation. J Neurosurg. 2010; 113 (6): 1186–94. https://doi.org/10.3171/2010.8.JNS10180.

33. Ramantani G., Koessler L., Colnat-Coulbois S., et al. Intracranial evaluation of the epileptogenic zone in regional infrasylvian polymicrogyria. Epilepsia. 2013; 54 (2): 296–304. https://doi.org/10.1111/j.1528-1167.2012.03667.x.

34. Chassoux F., Landre E., Rodrigo S., et al. Intralesional recordings and epileptogenic zone in focal polymicrogyria. Epilepsia. 2008; 49 (1): 51–64. https://doi.org/10.1111/j.1528-1167.2007.01267.x.

35. Maillard L., Koessler L., Colnat-Coulbois S., et al. Combined SEEG and source localisation study of temporal lobe schizencephaly and polymicrogyria. Clin Neurophysiol. 2009; 120 (9): 1628–36. https://doi.org/10.1016/j.clinph.2009.06.022.

36. Scherer C., Schuele S., Minotti L., et al. Intrinsic epileptogenicity of an isolated periventricular nodular heterotopia. Neurology. 2005; 65 (3): 495–6. https://doi.org/10.1212/01.wnl.0000172350.25380.c7.

37. Tassi L., Colombo N., Cossu M., et al. Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain. 2005; 128 (Pt. 2): 321–37. https://doi.org/10.1093/brain/awh357.

38. Pizzo F., Roehri N., Catenoix H., et al. Epileptogenic networks in nodular heterotopia: a stereoelectroencephalography study. Epilepsia. 2017; 58 (12): 2112–23. https://doi.org/10.1111/epi.13919.

39. Valton L., Guye M., McGonigal A., et al. Functional interactions in brain networks underlying epileptic seizures in bilateral diffuse periventricular heterotopia. Clin Neurophysiol. 2008; 119 (1): 212–23. https://doi.org/10.1016/j.clinph.2007.09.118.

40. Curatolo P., Jóźwiak S., Nabbout R. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol. 2012; 16 (6): 582–6. https://doi.org/10.1016/j.ejpn.2012.05.004.

41. Aubert S., Wendling F., Regis J., et al. Local and remote epileptogenicity in focal cortical dysplasias and neurodevelopmental tumours. Brain. 2009; 132 (Pt. 11): 3072–86. https://doi.org/10.1093/brain/awp242.

42. Sevy A., Gavaret M., Trebuchon A., et al. Beyond the lesion: the epileptogenic networks around cavernous angiomas. Epilepsy Res. 2014; 108 (4): 701–8. https://doi.org/10.1016/j.eplepsyres.2014.02.018.

43. Cossu M., Cardinale F., Castana L., et al. Stereoelectroencephalography in the presurgical evaluation of focal epilepsy: a retrospective analysis of 215 procedures. Neurosurgery. 2005; 57 (4): 706–18.

44. Shi J., Lacuey N., Lhatoo S. Surgical outcome of MRI-negative refractory extratemporal lobe epilepsy. Epilepsy Res. 2017; 133: 103–8. https://doi.org/10.1016/j.eplepsyres.2017.04.010.

45. Guenot M., Isnard J., Ryvlin P., et al. Neurophysiological monitoring for epilepsy surgery: the Talairach SEEG method. Indications, results, complications and therapeutic applications in a series of 100 consecutive cases. Stereotact Funct Neurosurg. 2001; 77 (1-4): 29–32. https://doi.org/10.1159/000064595.

46. Chassoux F., Landré E., Mellerio C., et al. Type II focal cortical dysplasia: electroclinical phenotype and surgical outcome related to imaging. Epilepsia. 2012; 53 (2): 349–58. https://doi.org/10.1111/j.1528-1167.2011.03363.x.

47. Nair D.R., Burgess R., McIntyre C.C., Lüders H. Chronic subdural electrodes in the management of epilepsy. Clin Neurophysiol. 2008; 119 (1): 11–28. https://doi.org/10.1016/j.clinph.2007.09.117.

48. Bulacio J.C., Jehi L., Wong C., et al. Long-term seizure outcome after resective surgery in patients evaluated with intracranial electrodes. Epilepsia. 2012; 53 (10): 1722–30. https://doi.org/10.1111/j.1528-1167.2012.03633.x.

49. Mullin J.P., Shriver M., Alomar S., et al. Is SEEG safe? A systematic review and meta-analysis of stereo-electroencephalography-related complications. Epilepsia. 2016; 57 (3): 386–401. https://doi.org/10.1111/epi.13298.